Observing Platelet Activability in a Once daily vs. a More frequent Aspirin intake regime
Suspended
- Conditions
- Cardiovascular patients myocardial infarcation angina pectoris
- Registration Number
- NL-OMON21826
- Lead Sponsor
- VUmc, VU university medical center
- Brief Summary
https://www.tandfonline.com/doi/pdf/10.1080/09537104.2020.1809643
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- Not specified
- Target Recruitment
- 85
Inclusion Criteria
Outpatients being treated for stable cardiovascular disease by the cardiology department.
- Stable cardiovascular disease defined as: coronary artery disease, peripheral vascular disease or previous myocardial infarction.
Exclusion Criteria
- Active bleeding
- Diabetes mellitus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method - PFA-200 parameters: closure time, flow slope, maximum rate of occlusion and area under the curve<br /><br>- Chrono-log LTA parameters: Amplitude of aggregation given in percentages and the area under the curve.<br /><br>- VerifyNow parameter: PRU <br /><br>- TBX2 serum levels. <br /><br>
- Secondary Outcome Measures
Name Time Method Platelet- , reticulated platelet- , leucocyte count and haemoglobin level